178 related articles for article (PubMed ID: 18379461)
1. [Antidepressants with different action mechanisms in the treatment of chronic daily headache].
Amelin AV; Tarasova SV; Ignatov IuD; Skoromets AA; Miatleva MI
Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(9):38-44. PubMed ID: 18379461
[TBL] [Abstract][Full Text] [Related]
2. Milnacipran and selective serotonin reuptake inhibitors in major depression.
Lopez-Ibor J; Guelfi JD; Pletan Y; Tournoux A; Prost JF
Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():41-6. PubMed ID: 8923126
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of milnacipran (serotonin noradrenalin reuptake inhibitor) on depression following mild and moderate traumatic brain injury.
Kanetani K; Kimura M; Endo S
J Nippon Med Sch; 2003 Aug; 70(4):313-20. PubMed ID: 12928711
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of milnacipran: an overview.
Montgomery SA; Prost JF; Solles A; Briley M
Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():47-51. PubMed ID: 8923127
[TBL] [Abstract][Full Text] [Related]
5. Double-blind study of the efficacy and safety of milnacipran and imipramine in elderly patients with major depressive episode.
Tignol J; Pujol-Domenech J; Chartres JP; Léger JM; Plétan Y; Tonelli I; Tournoux A; Pezous N
Acta Psychiatr Scand; 1998 Feb; 97(2):157-65. PubMed ID: 9517912
[TBL] [Abstract][Full Text] [Related]
6. A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache.
Bendtsen L; Jensen R; Olesen J
J Neurol Neurosurg Psychiatry; 1996 Sep; 61(3):285-90. PubMed ID: 8795600
[TBL] [Abstract][Full Text] [Related]
7. Comparative studies with milnacipran and tricyclic antidepressants in the treatment of patients with major depression: a summary of clinical trial results.
Kasper S; Pletan Y; Solles A; Tournoux A
Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():35-9. PubMed ID: 8923125
[TBL] [Abstract][Full Text] [Related]
8. Milnacipran for fibromyalgia: a useful addition to the treatment armamentarium.
Bernstein CD; Albrecht KL; Marcus DA
Expert Opin Pharmacother; 2013 May; 14(7):905-16. PubMed ID: 23506481
[TBL] [Abstract][Full Text] [Related]
9. [A comparative efficiency of amitriptyline, fluoxetine and maprotiline in prevention of migraine in attack-free period].
Amelin AV; Skoromets AA; Korenko LA; Tumelevich BCh; Gonchar MA
Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(8):20-3. PubMed ID: 10983362
[TBL] [Abstract][Full Text] [Related]
10. Milnacipran, a new serotonin and noradrenaline reuptake inhibitor: an overview of its antidepressant activity and clinical tolerability.
Puech A; Montgomery SA; Prost JF; Solles A; Briley M
Int Clin Psychopharmacol; 1997 Mar; 12(2):99-108. PubMed ID: 9219045
[TBL] [Abstract][Full Text] [Related]
11. Remarkable effect of milnacipran, a serotonin-noradrenalin reuptake inhibitor (SNRI), on depressive symptoms in patients with Parkinson's disease who have insufficient response to selective serotonin reuptake inhibitors (SSRIs): two case reports.
Takahashi H; Kamata M; Yoshida K; Higuchi H; Shimizu T
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):351-3. PubMed ID: 15694247
[TBL] [Abstract][Full Text] [Related]
12. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effects of the selective serotonin noradrenaline reuptake inhibitor milnacipran on depressive symptoms in patients with Alzheimer's disease.
Mizukami K; Hatanaka K; Tanaka Y; Sato S; Asada T
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):349-52. PubMed ID: 19166899
[TBL] [Abstract][Full Text] [Related]
14. Influence of the tyrosine hydroxylase val81met polymorphism and catechol-O-methyltransferase val158met polymorphism on the antidepressant effect of milnacipran.
Yoshida K; Higuchi H; Takahashi H; Kamata M; Sato K; Inoue K; Suzuki T; Itoh K; Ozaki N
Hum Psychopharmacol; 2008 Mar; 23(2):121-8. PubMed ID: 18023073
[TBL] [Abstract][Full Text] [Related]
15. The monoamine-mediated antiallodynic effects of intrathecally administered milnacipran, a serotonin noradrenaline reuptake inhibitor, in a rat model of neuropathic pain.
Obata H; Saito S; Koizuka S; Nishikawa K; Goto F
Anesth Analg; 2005 May; 100(5):1406-1410. PubMed ID: 15845695
[TBL] [Abstract][Full Text] [Related]
16. The interaction between antidepressant drugs and the pain-relieving effect of spinal cord stimulation in a rat model of neuropathy.
Song Z; Meyerson BA; Linderoth B
Anesth Analg; 2011 Nov; 113(5):1260-5. PubMed ID: 21788322
[TBL] [Abstract][Full Text] [Related]
17. [Serotonin-noradrenaline reuptake inhibitors(SNRIs)].
Ishigooka J
Nihon Rinsho; 2001 Aug; 59(8):1523-9. PubMed ID: 11519152
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy of milnacipran: placebo-controlled trials.
Lecrubier Y; Pletan Y; Solles A; Tournoux A; Magne V
Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():29-33. PubMed ID: 8923124
[TBL] [Abstract][Full Text] [Related]
19. A meta-analysis of clinical trials comparing milnacipran, a serotonin--norepinephrine reuptake inhibitor, with a selective serotonin reuptake inhibitor for the treatment of major depressive disorder.
Papakostas GI; Fava M
Eur Neuropsychopharmacol; 2007 Jan; 17(1):32-6. PubMed ID: 16762534
[TBL] [Abstract][Full Text] [Related]
20. Serotonin and noradrenaline reuptake inhibitors in animal models of pain.
Mochizucki D
Hum Psychopharmacol; 2004 Oct; 19 Suppl 1():S15-9. PubMed ID: 15378668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
